stocksSENORES
SENORES

Senores Pharmaceuticals Ltd.

1,509.80+12.3 (+0.82%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Senores Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual ReportsFY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Senores Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication4 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.
  2. Business Responsibility and Sustainability Reporting (BRSR)3 Sept 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    We are submitting herewith the copy of Business Responsibility and Sustainability Report of the Company for the financial year 2025-26.
  3. Reg. 34 (1) Annual Report3 Sept 2026
    Reg. 34 (1) Annual Report.
    We are submitting herewith the Annual Report of the Company for the financial year 2025-26.
  4. AGM3 Sept 2026
    Shareholder Meeting To Be Held On September 25, 2026 At 11:30 Am (IST)
    We are submitting herewith the notice convening the 9th Annual general Meeting of the Company and Annual Report for the financial year 2025-26
  5. Analyst / Investor Meet27 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on September 02, 2026
  6. Newspaper Publication27 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Senores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Report for the forthcoming Annual General Meeting of the Company
  7. Change in Management26 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Independent Director
  8. Appointment of Company Secretary / Compliance Officer26 Aug 2026
    Appointment of Company Secretary and Compliance Officer
    Senores Pharmaceuticals Limited has informed the Exchange regarding appointment of Company Secretary and Compliance Officer of the Company
  9. Acquisition26 Aug 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Senores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Subsidiary Company in Canada
  10. Acquisition26 Aug 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Senores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Wholly owned subsidiary in Mexico
  11. Outcome without intimation26 Aug 2026
    Board Meeting Outcome for Senores Pharmaceuticals Limited Has Informed The Exchange Regarding Outcome Of Board Meeting
    Senores Pharmaceuticals Limited has informed the Exchange about Outcome of Board Meeting held on August 26, 2026
  12. General24 Aug 2026
    Intimation For Giving Corporate Guarantee For Credit Facilities Availed By Apnar Pharma Private Limited, Subsidiary Of The Company From ICICI Bank Limited
    Senores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited, Subsidiary of the Company from ....
  13. Analyst / Investor Meet20 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on August 25, 2026
  14. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot
  15. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Vijaysinh Barot
  16. Postal Ballot4 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04, 2026
  17. Postal Ballot4 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot
  18. Newspaper Publication28 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Senores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30, 2026
  19. Analyst / Investor Meet27 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Senores Pharmaceuticals Limited has informed the Exchange regarding Audio recording of Earnings Conference Call for the quarter ended June 30, 2026
  20. Reg. 32 (1), (3) - Statement of Deviation & Variation27 Jul 2026
    Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On June 30, 2026
    Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible ....

Frequently Asked Questions

Where can I download the annual report of Senores Pharmaceuticals Ltd.?
Annual reports of Senores Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Senores Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Senores Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Senores Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Senores Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Senores Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Senores Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Senores Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Senores Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Senores Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Senores Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Senores Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Senores Pharmaceuticals Ltd. is INE0RB801010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Senores Pharmaceuticals Ltd. listed?
Senores Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is SENORES and the BSE code is -.
Where can I find the shareholding pattern of Senores Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Senores Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Senores Pharmaceuticals Ltd. on Sharpely?
Share price data for Senores Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.